133 related articles for article (PubMed ID: 18713146)
1. Rapamycin in islet transplantation: friend or foe?
Berney T; Secchi A
Transpl Int; 2009 Feb; 22(2):153-61. PubMed ID: 18713146
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin impairs proliferation of transplanted islet β cells.
Niclauss N; Bosco D; Morel P; Giovannoni L; Berney T; Parnaud G
Transplantation; 2011 Apr; 91(7):714-22. PubMed ID: 21297554
[TBL] [Abstract][Full Text] [Related]
3. Chemical immunosuppression in islet transplantation--friend or foe?
Chatenoud L
N Engl J Med; 2008 Mar; 358(11):1192-3. PubMed ID: 18337609
[No Abstract] [Full Text] [Related]
4. Sirolimus is associated with reduced islet engraftment and impaired beta-cell function.
Zhang N; Su D; Qu S; Tse T; Bottino R; Balamurugan AN; Xu J; Bromberg JS; Dong HH
Diabetes; 2006 Sep; 55(9):2429-36. PubMed ID: 16936190
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance.
Battaglia M; Stabilini A; Draghici E; Gregori S; Mocchetti C; Bonifacio E; Roncarolo MG
Diabetes; 2006 Jan; 55(1):40-9. PubMed ID: 16380475
[TBL] [Abstract][Full Text] [Related]
6. Islet transplantation in patients with diabetes mellitus: choice of immunosuppression.
Nanji SA; Shapiro AM
BioDrugs; 2004; 18(5):315-28. PubMed ID: 15377174
[TBL] [Abstract][Full Text] [Related]
7. Islet of Langerhans transplantation for the treatment of type 1 diabetes.
Bucher P; Mathe Z; Bosco D; Andres A; Bühler LH; Morel P; Berney T
Swiss Surg; 2003; 9(5):242-6. PubMed ID: 14601328
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin does not adversely affect intrahepatic islet engraftment in mice and improves early islet engraftment in humans.
Melzi R; Maffi P; Nano R; Sordi V; Mercalli A; Scavini M; Secchi A; Bonifacio E; Piemonti L
Islets; 2009; 1(1):42-9. PubMed ID: 21084848
[TBL] [Abstract][Full Text] [Related]
9. The effect of epitope-based ligation of ICAM-1 on survival and retransplantation of pig islets in nonhuman primates.
Lee JI; Kim J; Choi YJ; Park HJ; Park HJ; Wi HJ; Yoon S; Shin JS; Park JK; Jung KC; Lee EB; Kang HJ; Hwang ES; Kim SJ; Park CG; Park SH
Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29131413
[TBL] [Abstract][Full Text] [Related]
10. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity?
Desai NM; Goss JA; Deng S; Wolf BA; Markmann E; Palanjian M; Shock AP; Feliciano S; Brunicardi FC; Barker CF; Naji A; Markmann JF
Transplantation; 2003 Dec; 76(11):1623-5. PubMed ID: 14702535
[TBL] [Abstract][Full Text] [Related]
11. A combination regimen of low-dose bortezomib and rapamycin prolonged the graft survival in a murine allogeneic islet transplantation model.
Hong SH; Kim K; Shin JS; Chung H; Park CG
Immunol Lett; 2019 Dec; 216():21-27. PubMed ID: 31593743
[TBL] [Abstract][Full Text] [Related]
12. Use of low dose tacrolimus, mycophenolate mofetil and maintenance IL-2 receptor blockade in an islet transplant recipient.
Kaplan B; West P; Neeley H; Martellotto J; Iqbal R; Gangemi A; Hatipoglu B; Benedetti E; Oberholzer J
Clin Transplant; 2008; 22(2):250-3. PubMed ID: 18339148
[TBL] [Abstract][Full Text] [Related]
13. Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimen.
Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
Transpl Int; 2005 Nov; 18(11):1226-30. PubMed ID: 16221151
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression for pancreatic islet transplantation.
Berney T; Buhler LH; Majno P; Mentha G; Morel P
Transplant Proc; 2004 Mar; 36(2 Suppl):362S-366S. PubMed ID: 15041369
[TBL] [Abstract][Full Text] [Related]
15. Local release of rapamycin by microparticles delays islet rejection within the anterior chamber of the eye.
Fan Y; Zheng X; Ali Y; Berggren PO; Loo SCJ
Sci Rep; 2019 Mar; 9(1):3918. PubMed ID: 30850640
[TBL] [Abstract][Full Text] [Related]
16. Is islet transplantation ready for widespread use in diabetes?
Wang J; Wang QH; Xia T; Tan JM
Chin Med J (Engl); 2011 Mar; 124(6):935-8. PubMed ID: 21518606
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in rat-to-mouse islet transplantation.
Muller YD; Mai G; Morel P; Serre-Beinier V; Gonelle-Gispert C; Yung GP; Ehirchiou D; Wyss JC; Bigenzahn S; Irla M; Heusser C; Golshayan D; Seebach JD; Wekerle T; Bühler LH
PLoS One; 2010 Apr; 5(4):e10352. PubMed ID: 20436684
[TBL] [Abstract][Full Text] [Related]
18. Monotherapy with anti-LFA-1 monoclonal antibody promotes long-term survival of rat islet xenografts.
Tredget EB; Arefanian H; Gill RG; Rajotte RV; Rayat GR
Cell Transplant; 2008; 17(6):599-608. PubMed ID: 18819248
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus- and sirolimus-induced human β cell dysfunction is reversible and preventable.
Dai C; Walker JT; Shostak A; Padgett A; Spears E; Wisniewski S; Poffenberger G; Aramandla R; Dean ED; Prasad N; Levy SE; Greiner DL; Shultz LD; Bottino R; Powers AC
JCI Insight; 2020 Jan; 5(1):. PubMed ID: 31941840
[TBL] [Abstract][Full Text] [Related]
20. Engraftment versus immunosuppression: cost-benefit analysis of immunosuppression after intrahepatic murine islet transplantation.
Marzorati S; Melzi R; Citro A; Cantarelli E; Mercalli A; Scavini M; Piemonti L
Transplantation; 2014 May; 97(10):1019-26. PubMed ID: 24770621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
